Structural Characterization of a Potent Humanized Anti-Cd38 Antibody in Phase I

Acta Crystallographica Section A: Foundations and Advances - United States
doi 10.1107/s205327331408187x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

International Union of Crystallography (IUCr)

Related search

A Phase I Study of Farletuzumab, a Humanized Anti-Folate Receptor Α Monoclonal Antibody, in Patients With Solid Tumors

Investigational New Drugs
OncologyPharmacology
2014English

Mechanism of Action of a New Anti-Cd38 Antibody: Enhancing Myeloma Immunotherapy

Clinical Cancer Research
Cancer ResearchOncology
2019English

First-In-Human Phase I Study of Lumretuzumab, a Glycoengineered Humanized Anti-Her3 Monoclonal Antibody, in Patients With Metastatic or Advanced HER3-Positive Solid Tumors

Clinical Cancer Research
Cancer ResearchOncology
2015English

Preclinical Antilymphoma Activity of a Humanized Anti-Cd40 Monoclonal Antibody, SGN-40

Cancer Research
Cancer ResearchOncology
2005English

Chaperone-Assisted Soluble Expression of a Humanized Anti-Egfr ScFv Antibody in E. Coli

Advanced Pharmaceutical Bulletin
ToxicologyPharmaceuticsPharmacologyPharmaceutical Science
2015English

MORAb-202, an Antibody Drug Conjugate Utilizing Humanized Anti-Human FRa Farletuzumab and the Microtubule-Targeting Agent Eribulin, Has Potent Anti-Tumor Activity

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

The Mechanism of Action of the Anti-Cd38 Monoclonal Antibody Isatuximab in Multiple Myeloma

Clinical Cancer Research
Cancer ResearchOncology
2019English

Treatment of High-Grade Glioma Patients With the Humanized Anti-Epidermal Growth Factor Receptor (EGFR) Antibody H-R3: Report From a Phase I/Ii Trial

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2006English

Tocilizumab, a Humanized Anti-Interleukin-6 Receptor Antibody, for Treatment of Rheumatoid Arthritis

Open Access Rheumatology: Research and Reviews
Rheumatology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy